Literature DB >> 22891357

Natural course of extrahepatic nonmalignant partial portal vein thrombosis in patients with cirrhosis.

Angelo Luca1, Settimo Caruso, Mariapina Milazzo, Gianluca Marrone, Giuseppe Mamone, Francesca Crinò, Luigi Maruzzelli, Roberto Miraglia, Gaetano Floridia, Giovanni Vizzini.   

Abstract

PURPOSE: To define the natural course of extrahepatic nonmalignant partial portal vein thrombosis (PVT), including the progression from partial to complete PVT, in patients with cirrhosis who had undergone multidetector computed tomography (CT).
MATERIALS AND METHODS: This study was institutional review board and ethics committee approved. Written informed consent was obtained for each procedure. Forty-two consecutive patients with cirrhosis and untreated extrahepatic, nonmalignant partial PVT were followed up until the final clinical evaluation, liver transplantation, or death. Multidetector CT was used to evaluate the thrombus lumen occlusion, patent lumen area, thrombus area, total lumen area, and diameter of main portal vein, superior mesenteric vein, and splenic vein. Statistical analysis was performed with the Wilcoxon Mann-Whitney U test, χ2 test, Wilcoxon matched-pairs signed-rank test, life-table analysis, Kaplan-Meier method, and log-rank test, as appropriate.
RESULTS: After a mean follow-up period of 27 months, partial PVT worsened in 20 (48%) patients, improved in 19 (45%), and was stable in three (7%). The Kaplan-Meier probability of episodes of hepatic decompensation at 1 and 2 years was 41% and 57%; probability of hospital admission for hepatic decompensation, 37% and 54%; and survival rates, 77% and 57%, respectively. There was no clear association between progression or regression of partial PVT and clinical outcome. Multivariate analysis showed that the Child-Pugh score at diagnosis was the only independent predictor of survival (hazard ratio, 1.97; 95% confidence interval: 1.19, 3.23; P=.007) and hepatic decompensation (hazard ratio, 1.51; 95% confidence interval: 1.18, 1.19; P=.001).
CONCLUSION: Extrahepatic nonmalignant partial PVT improved spontaneously in 45% of patients with cirrhosis, and the progression of partial PVT was not associated with clinical outcome, which appeared to be dependent on the severity of cirrhosis. © RSNA, 2012.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22891357     DOI: 10.1148/radiol.12112236

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  42 in total

1.  Portal vein thrombosis after hepatectomy.

Authors:  Shohei Yoshiya; Ken Shirabe; Hidekazu Nakagawara; Yuji Soejima; Tomoharu Yoshizumi; Toru Ikegami; Yo-Ichi Yamashita; Norifumi Harimoto; Akihiro Nishie; Takeharu Yamanaka; Yoshihiko Maehara
Journal:  World J Surg       Date:  2014-06       Impact factor: 3.352

2.  Liver: PVT in cirrhosis, not always an innocent bystander.

Authors:  Marco Senzolo
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2014-12-16       Impact factor: 46.802

Review 3.  Portal vein thrombosis in cirrhosis: Controversies and latest developments.

Authors:  Damian J Harding; M Thamara P R Perera; Frederick Chen; Simon Olliff; Dhiraj Tripathi
Journal:  World J Gastroenterol       Date:  2015-06-14       Impact factor: 5.742

Review 4.  Portal vein thrombosis.

Authors:  Yogesh K Chawla; Vijay Bodh
Journal:  J Clin Exp Hepatol       Date:  2015-01-06

5.  Nonselective β-blockers may induce development of portal vein thrombosis in cirrhosis.

Authors:  Xing-Shun Qi; Ming Bai; Dai-Ming Fan
Journal:  World J Gastroenterol       Date:  2014-08-28       Impact factor: 5.742

Review 6.  Portal vein thrombosis in liver cirrhosis.

Authors:  Nao Kinjo; Hirofumi Kawanaka; Tomohiko Akahoshi; Yoshihiro Matsumoto; Masahiro Kamori; Yoshihiro Nagao; Naotaka Hashimoto; Hideo Uehara; Morimasa Tomikawa; Ken Shirabe; Yoshihiko Maehara
Journal:  World J Hepatol       Date:  2014-02-27

Review 7.  Vascular liver diseases on the clinical side: definitions and diagnosis, new concepts.

Authors:  Dominique-Charles Valla; Dominique Cazals-Hatem
Journal:  Virchows Arch       Date:  2018-03-24       Impact factor: 4.064

8.  Timing of the Treatment of Portal Vein Thrombosis in Patients with Cirrhosis: A German Hepatologist's Perspective.

Authors:  Martin Rössle; Michael Schultheiss
Journal:  J Transl Int Med       Date:  2018-03-28

9.  Timing of Anticoagulation for Portal Vein Thrombosis in Liver Cirrhosis: An Italian Internist's Perspective.

Authors:  Nicoletta Riva; Walter Ageno
Journal:  J Transl Int Med       Date:  2018-03-28

Review 10.  Portal vein thrombosis: should anticoagulation be used?

Authors:  Stephen E Congly; Samuel S Lee
Journal:  Curr Gastroenterol Rep       Date:  2013-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.